Articles Tagged With: enterobacteriaceae
-
IV to Oral Conversion of Antibiotic Therapy for Bacteremia Due to Enterobacteriaceae
Oral step-down antibiotic therapy (IV to oral conversion) is safe and effective in patients with bloodstream infection due to Enterobacteriaceae.
-
Plazomicin (Zemdri)
Plazomicin is an aminoglycoside recently approved by the Food and Drug Administration for treating complicated urinary tract infections.
-
Dealing With Multidrug-resistant Organisms on a National Level: CDC Successes and Problems on the Horizon
CDC efforts, implemented at the local level, have been associated with a modest reduction in the incidences of Escherichia coli and Klebsiella pneumoniae with an ESBL phenotype and a more dramatic reduction in carbapenem-resistant Enterobacteriaceae.
-
Decreasing Cross-Transmission of Carbapenemase-Producing Enterobacteriaceae
A bundled infection control intervention was shown to decrease cross-colonization, prevalence, and bloodstream infection of Klebsiella pneumonia carbapenemase-producing Enterobacteriaceae in long-term acute care hospitals, which may have far-reaching effects into the ICU.
-
Antibiotics for Traveler’s Diarrhea?
Foreign travel is associated with travelers’ diarrhea and the intestinal acquisition of extended-spectrum beta lactamase-producing Enterobacteriaceae, especially when travel is to South Asia. The risk of acquisition of resistant flora was almost doubled when antibiotics were used to treat the episode of diarrhea.